TARSUS PHARMACEUTICALS INC's ticker is TARS and the CUSIP is 87650L103. A total of 45 filers reported holding TARSUS PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $450,007 | +13.4% | 25,324 | +15.4% | 0.00% | 0.0% |
| Q2 2023 | $396,673 | +43.2% | 21,952 | -0.4% | 0.00% | – |
| Q1 2023 | $276,980 | -15.5% | 22,035 | -1.5% | 0.00% | -100.0% |
| Q4 2022 | $327,856 | +164.4% | 22,364 | +208.3% | 0.00% | – |
| Q3 2022 | $124,000 | +9.7% | 7,254 | -6.4% | 0.00% | – |
| Q2 2022 | $113,000 | +85.2% | 7,753 | +114.5% | 0.00% | – |
| Q1 2022 | $61,000 | -41.3% | 3,615 | -22.1% | 0.00% | – |
| Q4 2021 | $104,000 | +7.2% | 4,640 | +2.7% | 0.00% | – |
| Q3 2021 | $97,000 | -71.2% | 4,520 | -61.2% | 0.00% | – |
| Q2 2021 | $337,000 | +12.3% | 11,644 | +25.2% | 0.00% | – |
| Q1 2021 | $300,000 | -21.9% | 9,299 | 0.0% | 0.00% | -100.0% |
| Q4 2020 | $384,000 | – | 9,299 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 1,417,157 | $41,069,000 | 3.79% |
| Vivo Capital, LLC | 2,987,331 | $86,573,000 | 3.75% |
| Cormorant Asset Management, LP | 1,514,269 | $43,884,000 | 1.49% |
| Ghost Tree Capital, LLC | 170,000 | $4,927,000 | 1.35% |
| RTW INVESTMENTS, LP | 2,013,601 | $58,354,000 | 0.88% |
| COWEN AND COMPANY, LLC | 514,289 | $14,904,000 | 0.78% |
| Perceptive Advisors | 2,592,832 | $75,140,000 | 0.49% |
| Altium Capital Management LP | 70,573 | $2,045,000 | 0.47% |
| TimesSquare Capital Management, LLC | 686,705 | $19,901,000 | 0.16% |
| Jefferies Group LLC | 442,993 | $12,837,937 | 0.08% |